Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
South Korean military plans to launch new division for future warfare
-
7
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
[LOTTE CRISIS] Lotte crisis becomes boon for Axiall shareholders
By Korea HeraldPublished : June 14, 2016 - 16:11
[THE INVESTOR] Shareholders of Axiall have inadvertently benefited from the current crisis faced by South Korean retail giant Lotte, which resulted in Lotte Chemical dropping out of the race to acquire the U.S.-based chemicals firm.
Lotte Chemical and U.S. chemicals manufacturer Westlake Chemicals had previously been vying with one another to acquire Axiall.
In the face of competition from Lotte, Westlake had raised the stakes. On June 10, the company won the bid for Axiall after submitting a bidding price that was 46 percent higher than its original offer.
This came after Lotte Chemical withdrew from the race amid a prosecutorial investigation that started on that day and targeted all of Lotte’s affiliates in Seoul.
In January, Westlake offered $1.5 billion to acquire Axiall. It raised the price to $1.7 billion in April, but was again refused. The price Axiall eventually accepted was $33.5 per share, on the condition that the funds would be entirely in cash.
By Kim Ji-hyun (jemmie@heraldcorp.com)
Lotte Chemical and U.S. chemicals manufacturer Westlake Chemicals had previously been vying with one another to acquire Axiall.
In the face of competition from Lotte, Westlake had raised the stakes. On June 10, the company won the bid for Axiall after submitting a bidding price that was 46 percent higher than its original offer.
This came after Lotte Chemical withdrew from the race amid a prosecutorial investigation that started on that day and targeted all of Lotte’s affiliates in Seoul.
In January, Westlake offered $1.5 billion to acquire Axiall. It raised the price to $1.7 billion in April, but was again refused. The price Axiall eventually accepted was $33.5 per share, on the condition that the funds would be entirely in cash.
By Kim Ji-hyun (jemmie@heraldcorp.com)
-
Articles by Korea Herald
